An observational study in Hashimoto Disease, Pregnancy Related and Thyroid Dysfunction, sponsored by Centro Diagnostico Priamar. Status unknown. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-03.
Sponsored by Centro Diagnostico Priamar · Observational
The management of thyroid function in pregnancy has been object of several guidelines in the last years. Normal thyroid function reduces prenatal and post-natal risks and gestational complaints. Trimester specific reference values of thyroid hormones and thyroid stimulating hormone (TSH) are available for selected geographic population but its are not yet are available in our country. Hashimoto's thyroiditis (HT) is the most frequent autoimmune thyroid disease which can induce thyroid dysfunction, mainly sub-clinical hypothyroidism. Due to the large incidence in women HT and its potential link with thyroid dysfunction this disease could be search and monitored before pregnancy. Anyway a strong recommendation is to test TSH levels in all patients seeking pregnancy at risk for thyroid dysfunction for a history or current symptoms/signs of thyroid dysfunction, known positivity od thyroid autoimmunity or goiter, a history of neck radiation, age >30 years, diabetes mellitus, previous infertility or pregnant loss, morbid obesity, living in area of moderate-severe iodine deficiency or recent administration of drugs/substance interfering with thyroid function.
The aim of the study was to retrospectively evaluate from 2011 (data of publication of the first American Thyroid Association (ATA) guidelines for thyroid dysfunction in pregnancy) to now medical record of the a secondary level endocrine unit to verify the adherence to guidelines in the management of thyroid function in pregnant women with HT.
The investigators search
53 studies on the registry are indexed under Hashimoto Disease; 13 are open to participants now.
This study's planned enrollment of 100 is below the median of 112 across 22 observational studies indexed under Hashimoto Disease.
Browse Hashimoto Disease studies →This is the only study on the registry with Centro Diagnostico Priamar as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Women with Hashimoto's thyroidis or/and gloiter
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adult HT pregnant women and adult pregnant women with nodular goiter with or whiteout previous known hypothyroidism.
Exclusion Criteria:
Control of thyroid function in pregnancy
Thyroid hormones and TSH
Time frame: Through study completion, an average of 1 year
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2022; primary completion for Jul 2022, 6 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.